Clinical and Molecular Hepatology

"IL-6"

Original Article

Serum prohepcidin levels in chronic hepatitis C, alcoholic liver disease, and nonalcoholic fatty liver disease: Sang Hyub Lee, Sook-Hyang Jeong, Young Soo Park, Jin-Hyeok Hwang, Jin-Wook Kim, Nayoung Kim, Dong Ho Lee; Korean J Hepatol 2010;16(3):288-294.
Published online September 30, 2010; DOI: https://doi.org/10.3350/kjhep.2010.16.3.288

Abstract
PDF

Background/Aims

Patients with various chronic liver diseases frequently have increased body iron stores. Prohepcidin is an easily measurable precursor of hepcidin, which is a key regulator of iron homeostasis. This study investigated the serum prohepcidin levels in patients with various chronic liver diseases with various etiologies.

Methods

Serum prohepcidin levels were measured in patients with chronic hepatitis C (CH-C) (n=28), nonalcoholic fatty liver disease (NAFLD) (n=24), and alcoholic liver disease (ALD) (n=22), and in healthy controls (n=25) using commercial ELISA. Serum interleukin 6 (IL-6) levels and blood iron indices were also measured.

Results

The serum levels of both prohepcidin and IL-6 were significantly higher in CH-C patients than in healthy controls, and there was a positive correlation between the IL-6 and prohepcidin levels (r=0.505, p=0.020). The prohepcidin levels in ALD patients did not differ from those in controls, despite their significantly elevated IL-6 levels. There was a tendency for a negative correlation between serum prohepcidin levels and transferrin saturation in ALD patients (r=-0.420, p=0.051). Neither prohepcidin nor IL-6 was significantly elevated in the NAFLD group, despite the presence of elevated serum iron and ferritin levels.

Conclusions

The role of prohepcidin may differ in different human liver diseases. In the setting of CH-C, both the serum prohepcidin and IL-6 levels were significantly elevated and were positively correlated with each other.

Citations

Citations to this article as recorded by

Hemoglobin and Its Z Score Reference Intervals in Febrile Children: A Cohort Study of 98,572 Febrile Children
Chu-Yin Cheng, Ting-Hsuan Hsu, Ya-Ling Yang, Ying-Hsien Huang
Children.2023; 10(8): 1402. CrossRef
A Study of Changes in Prohepcidin and Iron Levels in Patients with Liver Transplant and Chronic Viral Hepatitis
Özlem ÖZDEMİR, Mesut AKARSU, Pınar TOSUN TAŞAR, Faize YÜKSEL, Aylin BACAKOĞLU, Tarkan ÜNEK, Fatih DEMİRKAN, Sedat KARADEMİR
Namık Kemal Tıp Dergisi.2023; 11(1): 66. CrossRef
Liver Sinusoidal Endothelial Cells at the Crossroad of Iron Overload and Liver Fibrosis
Sara Petrillo, Marta Manco, Fiorella Altruda, Sharmila Fagoonee, Emanuela Tolosano
Antioxidants & Redox Signaling.2021; 35(6): 474. CrossRef
Inflammatory and cardiovascular diseases biomarkers in chronic hepatitis C virus infection: A review
Ahmed Babiker, Mohamed Hassan, Safwan Muhammed, Gregory Taylor, Bhawna Poonia, Anoop Shah, Shashwatee Bagchi
Clinical Cardiology.2020; 43(3): 222. CrossRef
C-Reactive Protein Concentration Can Help to Identify Bacteremia in Children Visiting the Emergency Department: A Single Medical Center Experience
I-Min Chiu, Ying-Hsien Huang, Chih-Min Su, Chia-Te Kung, Chao-Jui Li, Chih-Ho Chen, Kuo-Su Tang, Kuang-Che Kuo
Pediatric Emergency Care.2020; 36(6): 291. CrossRef
Relationship of serum haemojuvelin and hepcidin levels with iron level and erythropoietin requirement in prevalent hepatitis C virus positive haemodialysis patients
Heba W. El Said, Khaled H. Abou Seif, Yasser S. Ahmed, Hesham A. Abou Elleil, Tamer W. El Said, Maha A. Behairy, Mohamed M. Mohamed, Fatma A. Ahmed
Nephrology.2018; 23(4): 323. CrossRef
Anemia in Kawasaki Disease: Hepcidin as a Potential Biomarker
Ying-Hsien Huang, Ho-Chang Kuo
International Journal of Molecular Sciences.2017; 18(4): 820. CrossRef
Hepcidin in morbidly obese women with non-alcoholic fatty liver disease
Teresa Auguet, Gemma Aragonès, Alba Berlanga, Salomé Martínez, Fàtima Sabench, Jessica Binetti, Carmen Aguilar, José Antonio Porras, Alicia Molina, Daniel Del Castillo, Cristóbal Richart, Pavel Strnad
PLOS ONE.2017; 12(10): e0187065. CrossRef
Alcoholic liver disease: Clinical and translational research
Manuela G. Neuman, Stephen Malnick, Yaakov Maor, Radu M. Nanau, Ehud Melzer, Peter Ferenci, Helmut K. Seitz, Sebastian Mueller, Haim Mell, Didier Samuel, Lawrence B. Cohen, Kusum K. Kharbanda, Natalia A. Osna, Murali Ganesan, Kyle J. Thompson, Iain H. McK
Experimental and Molecular Pathology.2015; 99(3): 596. CrossRef
The Wide and Complex Field of NAFLD Biomarker Research: Trends
Erika Wichro, Tanja Macheiner, Jasmin Schmid, Barbara Kavsek, Karine Sargsyan
ISRN Hepatology.2014; 2014: 1. CrossRef
Serum hepcidin levels and iron metabolism in obese children with and without fatty liver: case–control study
Fatih Demircioğlu, Gökhan Görünmez, Emine Dağıstan, Sevil Bilir Göksügür, Mervan Bekdaş, Mehmet Tosun, Betül Kızıldağ, Erol Kısmet
European Journal of Pediatrics.2014; 173(7): 947. CrossRef
Serum prohepcidin concentrations in rheumatoid arthritis and its relation to disease activity
Ahmad Emerah, Samah F. Abbas, Heba F. Pasha
Egyptian Rheumatology and Rehabilitation.2014; 41(3): 130. CrossRef
Lower serum prohepcidin levels associated with lower iron and erythropoietin requirements in hemodialysis patients with chronic hepatitis C
Yasar Caliskan, Berna Yelken, Abdullah Ozkok, Numan Gorgulu, Halil Yazici, Aysegul Telci, Alaattin Yildiz
BMC Nephrology.2012;[Epub] CrossRef
Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations
James E. Nelson, Elizabeth M. Brunt, Kris V. Kowdley
Hepatology.2012; 56(5): 1730. CrossRef
Serum prohepcidin levels are potential prognostic markers in patients with multiple myeloma
KOUICHI HARAGUCHI, HIROFUMI UTO, NOBUHITO OHNOU, MASAHITO TOKUNAGA, MAYUMI TOKUNAGA, ATAE UTSUNOMIYA, SHUICHI HANADA, HIROHITO TSUBOUCHI
Experimental and Therapeutic Medicine.2012; 4(4): 581. CrossRef

10,188 View
51 Download
Crossref

First

Page of 1

Last

Page Path

"IL-6"

Keywords

Publication year

Keywords

Publication Year

Funded articles

"IL-6"

ABOUT

BROWSE ARTICLES

FOR CONTRIBUTORS